Literature DB >> 31132669

LINC00909 promotes tumor progression in human glioma through regulation of miR-194/MUC1-C axis.

Zhentao Liu1, Chengyin Lu2, Hongkang Hu2, Zheng Cai3, Qiang Liang2, Wei Sun2, Lei Jiang4, Guohan Hu5.   

Abstract

Long non-coding RNAs (lncRNAs) play important roles in tumor progression. Whereas the roles and underlying mechanisms of LINC00909 (a newly discovered lncRNA) are still unclear in glioma progression. In the present study, we identified that LINC00909 expression was significantly elevated in glioma tissues and cell lines. High LINC00909 expression was associated with advanced WHO grade, high Karnofsky Performance Score (KPS), and poor prognosis in patients with glioma. Function assays showed that LINC00909 depletion inhibited glioma cells proliferation, invasion in vitro and reduced tumor growth in vivo. In the mechanism, we found that LINC00909 could act as a ceRNA to interact with miR-194 and thereby up-regulate the expression of MUC1-C, thus promoting the proliferation and invasion of glioma cells. Collectively, these data demonstrated that LINC00909/miR-194/MUC1-C axis regulated glioma progression and might act as a novel therapeutic target.
Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Glioma; LINC00909; MUC1-C; ceRNA; miR-194

Mesh:

Substances:

Year:  2019        PMID: 31132669     DOI: 10.1016/j.biopha.2019.108965

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  12 in total

1.  LncRNAs Associated with Chemoradiotherapy Response and Prognosis in Locally Advanced Rectal Cancer.

Authors:  Yiyi Zhang; Bingjie Guan; Yong Wu; Fan Du; Jinfu Zhuang; Yuanfeng Yang; Guoxian Guan; Xing Liu
Journal:  J Inflamm Res       Date:  2021-11-27

2.  Up-regulation of LINC00665 contributes to the progression of glioma and correlates with its MRI characteristics.

Authors:  Wangsheng Chen; Lan Hong; Changlong Hou; Genlin Zong; Jianhua Zhang
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

3.  MYC-activated lncRNA HNF1A-AS1 overexpression facilitates glioma progression via cooperating with miR-32-5p/SOX4 axis.

Authors:  Jianheng Wu; Rong Li; Linfan Li; Yimian Gu; Hui Zhan; Changbao Zhou; Chuanhong Zhong
Journal:  Cancer Med       Date:  2020-07-20       Impact factor: 4.452

Review 4.  Novel insights into the roles and therapeutic implications of MUC1 oncoprotein via regulating proteins and non-coding RNAs in cancer.

Authors:  Wei Li; Yineng Han; Chenmin Sun; Xue Li; Junhua Zheng; Jianping Che; Xudong Yao; Donald Kufe
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.556

5.  Comprehensive Analysis of Potential Biomarkers of Acute Lymphoblastic Leukemia in Children by Using a Competing Endogenous RNA Network.

Authors:  Xiao-Ying Lin; Ka-Yuk Yuen; Hai-Lei Chen; Miao-Na Shen; Yan Huang; Qian-Wen Huang; Yong Liu; Lu-Hong Xu
Journal:  J Oncol       Date:  2022-04-06       Impact factor: 4.375

6.  Five-mRNA Signature for the Prognosis of Breast Cancer Based on the ceRNA Network.

Authors:  Wenjie Shi; Daojun Hu; Sen Lin; Rui Zhuo
Journal:  Biomed Res Int       Date:  2020-09-03       Impact factor: 3.411

7.  circKIF4A promotes tumorogenesis of glioma by targeting miR-139-3p to activate Wnt5a signaling.

Authors:  Long-Wei Huo; Ya-Fei Wang; Xiao-Bin Bai; Hu-Lin Zheng; Mao-De Wang
Journal:  Mol Med       Date:  2020-04-08       Impact factor: 6.354

8.  Transcription factor AP-4 (TFAP4)-upstream ORF coding 66 aa inhibits the malignant behaviors of glioma cells by suppressing the TFAP4/long noncoding RNA 00520/microRNA-520f-3p feedback loop.

Authors:  Yipeng Wang; Chunqing Yang; Xiaobai Liu; Jian Zheng; Fangfang Zhang; Di Wang; Yixue Xue; Xiaozhi Li; Shuyuan Shen; Lianqi Shao; Yang Yang; Libo Liu; Jun Ma; Yunhui Liu
Journal:  Cancer Sci       Date:  2020-02-11       Impact factor: 6.716

9.  Inhibition of MUC1 exerts cell-cycle arrest and telomerase suppression in glioblastoma cells.

Authors:  Sojin Kim; Youngbeom Seo; Tamrin Chowdhury; Hyeon Jong Yu; Chae Eun Lee; Kyung-Min Kim; Ho Kang; Hak Jae Kim; Soo-Ji Park; Kyoungmi Kim; Chul-Kee Park
Journal:  Sci Rep       Date:  2020-10-26       Impact factor: 4.379

10.  Elevated LINC00909 Promotes Tumor Progression of Ovarian Cancer via Regulating the miR-23b-3p/MRC2 Axis.

Authors:  Xu Yang; Guixia Wu; Fan Yang; Lang He; Xiaohui Xie; Lan Li; Lei Yang; Yulan Ma; Qin Zhang; Jiao Chen; SiYing Zou; Qian Han; Yan Wang; Shuai Liu; Juan Li; Bin Han; KaiJiang Liu
Journal:  Oxid Med Cell Longev       Date:  2021-07-21       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.